Skip to main content

Chemoembolization of HCC: Time for Technical Standardization, or Is It Too Late?

This is a preview of subscription content, access via your institution.

References

  1. 1.

    Basile A, Carrafiello G, Ierardi AM, Tsetis D, Brountzos E. Quality-improvement guidelines for hepatic transarterial chemoembolization. Cardiovasc Interv Radiol. 2012;35(4):765–74.

    Article  Google Scholar 

  2. 2.

    Deschamps F, Harris KR, Moine L, et al. Pickering-emulsion for liver trans-arterial chemo-embolization with oxaliplatin. Cardiovasc Interv Radiol. 2018;41(5):781–8.

    Article  Google Scholar 

  3. 3.

    Deschamps F, Moine L, Isoardo T, et al. Parameters for stable water-in-oil lipiodol emulsion for liver trans-arterial chemo-embolization. Cardiovasc Interv Radiol. 2017;40(12):1927–32.

    Article  CAS  Google Scholar 

  4. 4.

    European Association For The Study Of The L, European Organisation For R, Treatment Of C. EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol. 2012;56(4):908–43.

    Article  Google Scholar 

  5. 5.

    Gaba RC, Lokken RP, Hickey RM, et al. Quality improvement guidelines for transarterial chemoembolization and embolization of hepatic malignancy. J Vasc Interv Radiol. 2017;28(9):1210–23.

    Article  PubMed  Google Scholar 

  6. 6.

    Golfieri R, Giampalma E, Renzulli M, et al. Randomised controlled trial of doxorubicin-eluting beads vs conventional chemoembolisation for hepatocellular carcinoma. Br J Cancer. 2014;111(2):255–64.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. 7.

    Guiu B, Chevallier P, Assenat E, et al. Idarubicin-loaded beads for chemoembolization of hepatocellular carcinoma: the IDASPHERE II single-arm phase II trial. Radiology. 2019;291(3):801–8.

    Article  PubMed  Google Scholar 

  8. 8.

    He MK, Zou RH, Wei W, et al. Comparison of stable and unstable ethiodized oil emulsions for transarterial chemoembolization of hepatocellular carcinoma: results of a single-center double-blind prospective randomized controlled trial. J Vasc Interv Radiol. 2018;29(8):1068–77.

    Article  PubMed  Google Scholar 

  9. 9.

    Lammer J, Malagari K, Vogl T, et al. Prospective randomized study of doxorubicin-eluting-bead embolization in the treatment of hepatocellular carcinoma: results of the PRECISION V study. Cardiovasc Interv Radiol. 2010;33(1):41–52.

    Article  Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to Olivier Pellerin.

Ethics declarations

Conflict of interest

None of the authors have any conflict of interest or financial disclosures to declare.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Pellerin, O., Boeken, T. & Guiu, B. Chemoembolization of HCC: Time for Technical Standardization, or Is It Too Late?. Cardiovasc Intervent Radiol 42, 1329–1330 (2019). https://doi.org/10.1007/s00270-019-02268-9

Download citation